Skip to main navigationSkip to main content
The University of Southampton
Southampton Health Technology Assessments Centre

Kidney cancers

Click on the title for more information (where available).

Cooper, K., Loveman, E., Onyimadu, O., Scott, D., Colquitt, J., Shepherd, J., Pembrolizumab in combination with axitinib for untreated advanced renal cell carcinoma: A Single Technology Appraisal. Southampton Health Technology Assessments Centre (SHTAC), 2019.

Shepherd, J., Lord, J., Harris, P., Onyimadu, O., Frampton, G., & Chorozoglou, M. Cabozantinib for untreated locally advanced or metastatic renal cell carcinoma. A Single Technology Appraisal. Southampton Health Technology Assessments Centre (SHTAC), 2018.

Privacy Settings